File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/nmo.14572
- Scopus: eid_2-s2.0-85151473225
- PMID: 37010885
- WOS: WOS:000961962600001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: A systematic review and meta-analysis on the prevalence and clinical characteristics of dysphagia in patients with dermatomyositis
Title | A systematic review and meta-analysis on the prevalence and clinical characteristics of dysphagia in patients with dermatomyositis |
---|---|
Authors | |
Keywords | Dermatomyositis dysphagia esophagus myositis skin disorders swallowing |
Issue Date | 2023 |
Citation | Neurogastroenterology and Motility, 2023, v. 35, n. 9, article no. e14572 How to Cite? |
Abstract | Background: Dermatomyositis (DM) is a rare autoimmune disease characterized by distinctive skin rash, muscle inflammation with symmetrical and progressive muscle weakness, and elevated serum levels of muscle-associated enzymes. DM may affect skeletal muscles involved in swallowing, leading to dysphagia, which can negatively impact individual's physical and psychosocial well-being. Despite this, dysphagia in patients with DM remains poorly understood. This systematic review and meta-analysis aimed to evaluate the prevalence and clinical features of dysphagia in patients with DM and juvenile DM (JDM). Methods: Four electronic databases were systematically searched until September 2022. Studies with patients with DM or JDM and dysphagia were included. The pooled prevalence of all included studies was calculated, and the clinical characteristics of dysphagia were qualitatively analyzed. Key Results: Thirty-nine studies with 3335 patients were included. The overall pooled prevalence of dysphagia was 32.3% (95% CI: 0.270, 0.373) in patients with DM and 37.7% (95% CI: −0.031, 0.785) in patients with JDM. Subgroup analyses revealed that Sweden had the highest prevalence (66.7% [95% CI: 0.289, 1.044]), whereas Tunisia had the lowest prevalence (14.3% [95% CI: −0.040, 0.326]). Moreover, South America had the highest prevalence (47.0% [95% CI: 0.401, 0.538]), whereas Africa had the lowest prevalence (14.3% [95% CI: −0.040, 0.326]). Dysphagia in patients with DM and JDM was characterized by both oropharyngeal and esophageal dysfunctions, with predominant difficulties in motility. Conclusions & Inferences: Our findings showed that dysphagia affects one in three patients with DM or JDM. However, the documentation on the diagnosis and management of dysphagia in the literature is inadequate. Our results highlighted the need to use both clinical and instrumental assessments to evaluate swallowing function in this population. |
Persistent Identifier | http://hdl.handle.net/10722/334911 |
ISSN | 2023 Impact Factor: 3.5 2023 SCImago Journal Rankings: 1.312 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cheng, Ivy | - |
dc.contributor.author | Wong, Christina Sze Man | - |
dc.date.accessioned | 2023-10-20T06:51:40Z | - |
dc.date.available | 2023-10-20T06:51:40Z | - |
dc.date.issued | 2023 | - |
dc.identifier.citation | Neurogastroenterology and Motility, 2023, v. 35, n. 9, article no. e14572 | - |
dc.identifier.issn | 1350-1925 | - |
dc.identifier.uri | http://hdl.handle.net/10722/334911 | - |
dc.description.abstract | Background: Dermatomyositis (DM) is a rare autoimmune disease characterized by distinctive skin rash, muscle inflammation with symmetrical and progressive muscle weakness, and elevated serum levels of muscle-associated enzymes. DM may affect skeletal muscles involved in swallowing, leading to dysphagia, which can negatively impact individual's physical and psychosocial well-being. Despite this, dysphagia in patients with DM remains poorly understood. This systematic review and meta-analysis aimed to evaluate the prevalence and clinical features of dysphagia in patients with DM and juvenile DM (JDM). Methods: Four electronic databases were systematically searched until September 2022. Studies with patients with DM or JDM and dysphagia were included. The pooled prevalence of all included studies was calculated, and the clinical characteristics of dysphagia were qualitatively analyzed. Key Results: Thirty-nine studies with 3335 patients were included. The overall pooled prevalence of dysphagia was 32.3% (95% CI: 0.270, 0.373) in patients with DM and 37.7% (95% CI: −0.031, 0.785) in patients with JDM. Subgroup analyses revealed that Sweden had the highest prevalence (66.7% [95% CI: 0.289, 1.044]), whereas Tunisia had the lowest prevalence (14.3% [95% CI: −0.040, 0.326]). Moreover, South America had the highest prevalence (47.0% [95% CI: 0.401, 0.538]), whereas Africa had the lowest prevalence (14.3% [95% CI: −0.040, 0.326]). Dysphagia in patients with DM and JDM was characterized by both oropharyngeal and esophageal dysfunctions, with predominant difficulties in motility. Conclusions & Inferences: Our findings showed that dysphagia affects one in three patients with DM or JDM. However, the documentation on the diagnosis and management of dysphagia in the literature is inadequate. Our results highlighted the need to use both clinical and instrumental assessments to evaluate swallowing function in this population. | - |
dc.language | eng | - |
dc.relation.ispartof | Neurogastroenterology and Motility | - |
dc.subject | Dermatomyositis | - |
dc.subject | dysphagia | - |
dc.subject | esophagus | - |
dc.subject | myositis | - |
dc.subject | skin disorders | - |
dc.subject | swallowing | - |
dc.title | A systematic review and meta-analysis on the prevalence and clinical characteristics of dysphagia in patients with dermatomyositis | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1111/nmo.14572 | - |
dc.identifier.pmid | 37010885 | - |
dc.identifier.scopus | eid_2-s2.0-85151473225 | - |
dc.identifier.volume | 35 | - |
dc.identifier.issue | 9 | - |
dc.identifier.spage | article no. e14572 | - |
dc.identifier.epage | article no. e14572 | - |
dc.identifier.eissn | 1365-2982 | - |
dc.identifier.isi | WOS:000961962600001 | - |